Astrazeneca Pharma India up 6% on core profit growth in March qtr

Astrazeneca Pharma India

31/05/2023 07:53

** Shares of Astrazeneca Pharma India Ltd  ASTR.NS  climb as
much as 6.16% to a near five month high of 3,549.90 rupees
    ** Uptick after co reports 58% Y/Y rise in standalone core
profit to 598.49 mln rupees ($7.2 mln) for Match qtr
    ** Core profit margin expands to 21% vs 16.36% a year
earlier
    ** Revenue up 23%, while profit after tax (PAT) fell 38% to
172.71 mln rupees due to an exceptional item 
    ** Co declares a final dividend of 16 rupees per share
    ** Stock most active in six months, with trading volume of
57,429 shares as of 12:10 p.m. IST, 12.1 times the 30-day avg -
Refinitiv data
    ** Relative strength index of the stock is 75, suggesting it
may be overbought

    (1 USD = 82.6686 rupees)

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))